Adjuvant immunotherapy with intrapleural Streptococcus pyogenes (OK-432) in lung cancer patients after resection (Q72790099)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954529%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Adjuvant immunotherapy with intrapleural Streptococcus pyogenes (OK-432) in lung cancer patients after resection (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954529%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

1 reference

Streptococcus pyogenes

object named as

Streptococcus pyogenes

1 reference

Y C Lee

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954529%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

S P Luh

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954529%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

R M Wu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954529%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

C J Lee

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954529%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 October 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954529%20AND%20SRC:MED&resulttype=core&format=json

Cancer Immunology, Immunotherapy

29 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954529%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954529%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954529%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

269-274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954529%20AND%20SRC:MED&resulttype=core&format=json

Cultured human monocytes, granulocytes and a monoblastoid cell line (THP-1) synthesize and secrete immunosuppressive acidic protein (a type of alpha 1-acid glycoprotein)

29 October 2019

cites work

1 reference

12 December 2020

Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients

1 reference

12 December 2020

Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.

1 reference

12 December 2020

Postoperative intrapleural BCG in lung cancer: lack of efficacy and possible enhancement of tumour growth

1 reference

12 December 2020

Clinical value of immunotherapy for lung cancer by the streptococcal preparation OK-432

1 reference

12 December 2020

Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha

1 reference

12 December 2020

Management of malignant pleural effusion: an overview

1 reference

12 December 2020

Lysis of fresh human tumor cells by autologous peripheral blood lymphocytes and pleural effusion lymphocytes activated by OK432

1 reference

12 December 2020

Increased levels of soluble interleukin-2 receptors in serum of patients with lung cancer

1 reference

12 December 2020

Postoperative empyema improves survival in lung cancer. Documentation and analysis of a natural experiment

1 reference

12 December 2020

New approach to management of malignant ascites with a streptococcal preparation, OK-432. I. Improvement of host immunity and prolongation of survival

1 reference

12 December 2020

Cytotoxic cells induced in tumor-bearing rats by a streptococcus preparation (OK-432)

1 reference

12 December 2020

New approach to management of malignant ascites with streptococcal preparation OK-432. III. OK-432 attracts natural killer cells through a chemotactic factor released from activated neutrophils

1 reference

12 December 2020

Comparison of OK-432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A Randomized Trial

1 reference

12 December 2020

New approach to management of malignant ascites with a streptococcal preparation, OK-432. II. Intraperitoneal inflammatory cell-mediated tumor cell destruction

1 reference

12 December 2020

Surgical adjuvant intrapleural BCG treatment for stage I non-small cell lung cancer. Preliminary report of the National Cancer Institute Lung Cancer Study Group

1 reference

12 December 2020

Adjuvant immunotherapy with BCG in squamous cell bronchial carcinoma

1 reference

12 December 2020

Regional immunotherapy with intrapleural BCG for lung cancer

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01525991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7954529%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference